San Carlos, CA, United States of America

Arthur Lee

This inventor holds 21 USPTO granted patents and 4 published patent applications and 7 EPO patents, primarily in Biopharmaceutical Compounds. Top assignees: Pfizer Corporation, Bolt Biotherapeutics, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur Lee. Retrieved from https://idiyas.com/inventor/arthur-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 95.2

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 75(Granted Patents)

Location History:

Gaithersburg, MD (US) (2016 - 2017)
Littleton, MA (US) (2018 - 2019)
Redwood City, CA (US) (2022)
San Jose, CA (US) (2018 - 2023)
San Carlos, CA (US) (2019 - 2023)

Company Filing History:

Bolt Biotherapeutics, Inc.

patents

5 out of 1,430

The Brigham and Women's Hospital, Inc.

patents

4. 5 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 4 out of 5,519

Leland Stanford Junior University

patents

6. 1 out of 619

University of Houston System

patents

7. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Anti-HER2

Immunoconjugates

Bicyclic-Fused Compounds

ALK2 Inhibitors

BMP Signaling

Antibody Adjuvants

Triazine Compounds

Anti-Oxidant Compounds

Compositions

Methods

Heteroaryl Compounds

Modulators

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678513 - Anti-HER2 immunoconjugates, and uses thereof (2026-07-14),

2. 12570610 - Macromolecule-supported aminobenzazepine compounds (2026-03-10),

3. 12202836 - Bicyclic-fused heteroaryl or aryl compounds (2025-01-21),

4. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

5. 11654147 - ALK2 inhibitors and methods for inhibiting BMP signaling (2023-05-23),

6. 11547761 - Antibody adjuvant conjugates (2023-01-10),

7. 11400164 - Immunoconjugates targeting HER2 (2022-08-02),

8. 11242444 - Triazine compounds, compositions, and methods (2022-02-08),

9. 11142695 - Anti-oxidant compounds and compositions (2021-10-12),

10. 11110178 - Antibody adjuvant conjugates (2021-09-07),

11. 11026947 - ALK2 inhibitors and methods for inhibiting BMP signaling (2021-06-08),

12. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),

13. 10675358 - Antibody adjuvant conjugates (2020-06-09),

14. 10513521 - Compositions and methods for inhibiting BMP (2019-12-24),

15. 10329302 - Bicyclic-fused heteroaryl or aryl compounds (2019-06-25),

Title: The Innovative Journey of Arthur Lee

Introduction: Arthur Lee, a visionary inventor based in San Carlos, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Arthur Lee's most recent patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: With over two decades of experience in the tech industry, Arthur Lee has a proven track record of developing innovative solutions. He has held key positions in several renowned tech companies, leading research and development teams to success.

Collaborations: Throughout his career, Arthur Lee has collaborated with top researchers, engineers, and scientists from prestigious universities and research institutions worldwide. His collaborative efforts have resulted in pioneering inventions that have shaped the future of technology.

Conclusion: Arthur Lee's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to pushing the boundaries of technology continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.